tenofovir has been researched along with Acute Symptom Flare in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 6 (85.71) | 2.80 |
| Authors | Studies |
|---|---|
| Chien, RN; Jeng, WJ; Liaw, YF; Liu, YC; Peng, CW | 1 |
| Chien, RN; Liaw, YF | 1 |
| Jin, Y; Lu, L; Mao, Y; Wang, S; Yang, S; Yu, Y; Zhang, L; Zhao, A | 1 |
| Chien, RN; Jeng, WJ; Liaw, YF; Liu, YC; Peng, CW; Yang, HI | 1 |
| Cho, EJ; Jang, H; Kim, TM; Kim, YJ; Lee, HG; Lee, JH; Lee, YB; Yoon, JH; Yu, SJ | 1 |
| Acar, Ş; Çakmak, E; Eminler, AT; Fidan, S; Hülagü, S; İskender, G; Koksal, AS; Sezikli, M; Şirin, G; Toka, B; Üsküdar, O; Uslan, MI; Yildirim, AE | 1 |
| Buti, M; Crans, G; Flaherty, J; Flisiak, R; Gaggar, A; Gane, E; Janssen, HLA; Jump, B; Kaita, K; Kitrinos, K; Manns, M; Marcellin, P; Op den Brouw, M; Wong, DK | 1 |
1 review(s) available for tenofovir and Acute Symptom Flare
| Article | Year |
|---|---|
Current Trend in Antiviral Therapy for Chronic Hepatitis B.
Topics: Antiviral Agents; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Nucleosides; Nucleotides; Randomized Controlled Trials as Topic; Symptom Flare Up; Tenofovir; Treatment Outcome | 2022 |
2 trial(s) available for tenofovir and Acute Symptom Flare
| Article | Year |
|---|---|
Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study.
Topics: Antiviral Agents; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Prospective Studies; Rituximab; Symptom Flare Up; Tenofovir | 2023 |
Safety and efficacy of stopping tenofovir disoproxil fumarate in patients with chronic hepatitis B following at least 8 years of therapy: a prespecified follow-up analysis of two randomised trials.
Topics: Adult; Alanine Transaminase; DNA, Viral; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lipase; Liver; Male; Middle Aged; Nucleotides; Reverse Transcriptase Inhibitors; Symptom Flare Up; Tenofovir; Withholding Treatment | 2019 |
4 other study(ies) available for tenofovir and Acute Symptom Flare
| Article | Year |
|---|---|
Off-tenofovir hepatitis flares in HBeAg-negative patients occur earlier, more frequent and severe than those off-entecavir therapies.
Topics: Antiviral Agents; DNA, Viral; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Retrospective Studies; Symptom Flare Up; Tenofovir; Treatment Outcome | 2022 |
Prophylactic effect of tenofovir on viral reactivation in immunocompromised pregnant women living with hepatitis B virus.
Topics: Antiviral Agents; Female; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Pregnancy; Pregnant Women; Symptom Flare Up; Tenofovir; Viral Load | 2022 |
A switch from tenofovir to entecavir prior to hepatitis B treatment cessation is associated with a reduced risk of off-therapy relapse: An observational study.
Topics: Antiviral Agents; DNA, Viral; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Recurrence; Symptom Flare Up; Tenofovir; Treatment Outcome; Withholding Treatment | 2022 |
HBV flare associated with immunosuppressive treatments: it is still dangerous in the third-generation antivirals era.
Topics: Alanine Transaminase; Antiviral Agents; Female; Guanine; Hepatitis B; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Symptom Flare Up; Tenofovir | 2020 |